Department of Nephrology , AMNCH, Tallaght , Dublin , Ireland.
Department of Palliative Care Medicine , AMNCH, Tallaght , Dublin , Ireland.
Clin Kidney J. 2013 Dec;6(6):604-8. doi: 10.1093/ckj/sft117. Epub 2013 Oct 10.
Although patients with end-stage kidney disease (ESKD) have a shortened life expectancy, their end-of-life (EOL) care is suboptimal. The aim of this study was to review the utilization of specialist palliative care (SPC) in patients with ESKD in Dublin, Ireland.
We conducted a retrospective chart review of prevalent patients with ESKD who died between January 2005 and December 2009 at a tertiary referral centre. We recorded SPC referrals, modality of renal replacement therapy, age and place of death.
Of 131 included patients, 88 (67.2%) were male, mean age at death was 63.2 ± 15.1 years and 102 (77.9%) were treated with haemodialysis. Forty-eight patients (36.7%) were referred to SPC, who were involved in the patients' management for a median of 12 days (range 0-907) before death. A total 104 patients (79.4%) died in an acute hospital, 19 (14.5%) died at home, 3 (2.3%) died in an inpatient hospice and the place of death was unknown for 5 patients (3.8%). Dialysis was withdrawn prior to death in 50 patients (38.1%), with a median time to death after withdrawal of dialysis of 6 days (0-105 days). A discussion regarding the withdrawal of dialysis was more frequently held with family member(s) rather than the patient.
SPC was involved in the antemortem care of ∼1/3 of the patients with the majority of referrals placed at a late stage. Given the short timeframe until death once dialysis is withdrawn, it is imperative that appropriate EOL care is instituted. This study identifies an underutilization of SPC and improved integration of palliative care and nephrology services may optimize EOL care for patients with ESKD.
尽管终末期肾病(ESKD)患者的预期寿命较短,但他们的临终关怀并不理想。本研究旨在回顾爱尔兰都柏林 ESKD 患者接受专科姑息治疗(SPC)的情况。
我们对 2005 年 1 月至 2009 年 12 月期间在一家三级转诊中心死亡的现有 ESKD 患者进行了回顾性病历审查。我们记录了 SPC 转诊、肾脏替代治疗方式、年龄和死亡地点。
在 131 名纳入的患者中,88 名(67.2%)为男性,死亡时的平均年龄为 63.2±15.1 岁,102 名(77.9%)接受血液透析治疗。48 名(36.7%)患者被转诊至 SPC,在死亡前的中位时间为 12 天(0-907 天)参与患者管理。共有 104 名(79.4%)患者在急性医院死亡,19 名(14.5%)在家中死亡,3 名(2.3%)在住院临终关怀病房死亡,5 名(3.8%)患者的死亡地点不详。50 名(38.1%)患者在死亡前停止透析,停止透析后死亡的中位时间为 6 天(0-105 天)。与患者相比,更频繁地与家属讨论停止透析的问题。
大约 1/3 的患者在生前接受了 SPC 治疗,大多数转诊是在晚期进行的。鉴于一旦停止透析,死亡时间很短,因此必须提供适当的临终关怀。本研究发现 SPC 利用不足,改善姑息治疗和肾病科服务的整合可能会优化 ESKD 患者的临终关怀。